Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 4831 AL 4845

Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease

Teipel SJ, Sabri O, Grothe M, Barthel H, Prvulovic D, Buerger K, Bokde AL, Ewers M, Hoffmann W, Hampel H.

J Alzheimers Dis. 2013;33 Suppl 1:S329-47. doi: 10.3233/JAD-2012-129030.

Biomarkers for Alzheimer's disease: showing the way or leading us astray?

Quinn JF.

J Alzheimers Dis. 2013;33 Suppl 1(Suppl 1):S371-6. doi: 10.3233/JAD-2012-129022.

Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia

Le Bastard N, Coart E, Vanderstichele H, Vanmechelen E, Martin JJ, Engelborghs S.

J Alzheimers Dis. 2013;33(1):117-31. doi: 10.3233/JAD-2012-121246.

At the end of a very hard day, people find some reason to believe

Robert P.

J Alzheimers Dis. 2013;34(1):295-6. doi: 10.3233/JAD-121637.

Targeted recruitment using cerebrospinal fluid biomarkers: implications for Alzheimer's disease therapeutic trials

Barnes J, Bartlett JW, Fox NC, Schott JM.

J Alzheimers Dis. 2013;34(2):431-7. doi: 10.3233/JAD-121936.

[A new definition for Alzheimer's disease]

Dubois B.

Bull Acad Natl Med. 2013 Jan;197(1):143-53; discussion 153-6.

Alzheimer's disease dementia guidelines for diagnostic testing: a systematic review

Arevalo-Rodriguez I, Pedraza OL, Rodríguez A, Sánchez E, Gich I, Solà I, Bonfill X, Alonso-Coello P.

Am J Alzheimers Dis Other Demen. 2013 Mar;28(2):111-9. doi: 10.1177/1533317512470209. Epub 2013 Jan 2.

Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection

Risacher SL, Saykin AJ.

Annu Rev Clin Psychol. 2013;9:621-48. doi: 10.1146/annurev-clinpsy-050212-185535. Epub 2013 Jan 7.

Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers

Kosicek M, Hecimovic S.

Int J Mol Sci. 2013 Jan 10;14(1):1310-22. doi: 10.3390/ijms14011310.

Plasma proteomics for the identification of Alzheimer disease

Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):337-42. doi: 10.1097/WAD.0b013e31827b60d2.

A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease

Peters KR, Lynn Beattie B, Feldman HH, Illes J.

Prog Neurobiol. 2013 Nov;110:114-23. doi: 10.1016/j.pneurobio.2012.12.001. Epub 2013 Jan 21.

State of the science: use of biomarkers and imaging in diagnosis and management of Alzheimer disease

Fraller DB.

J Neurosci Nurs. 2013 Apr;45(2):63-70. doi: 10.1097/JNN.0b013e3182829024.

Alzheimer disease biomarkers and insights into mild cognitive impairment

Knopman DS.

Neurology. 2013 Mar 12;80(11):978-80. doi: 10.1212/WNL.0b013e31828728ac. Epub 2013 Feb 6.

Imaging epigenetics in Alzheimer's disease

Lista S, Garaci FG, Toschi N, Hampel H.

Curr Pharm Des. 2013;19(36):6393-415. doi: 10.2174/13816128113199990370.

[Posterior variant of Alzheimer's disease and other atypical symptom pictures]

Remes AM, Vanninen R, Jokinen H, Hallikainen M, Erkinjuntti T.

Duodecim. 2013;129(3):244-50.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias